| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,010 | 0,020 | 09.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| REVITALIST LIFESTYLE AND WELLNESS Aktie jetzt für 0€ handeln | |||||
| 18.02.25 | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | 371 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 94,93 | +1,62 % | Citizens raises Roku stock price target to $160 on growth catalysts | ||
| SERNOVA BIOTHERAPEUTICS | 0,079 | -6,55 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 83,80 | -0,95 % | Boston Scientific reportedly plans to consolidate some Texas operations with new facility | ||
| PAUL HARTMANN | 227,00 | -0,87 % | Januar bis September 2025: PAUL HARTMANN steigert Umsatz trotz schwächerer Absatzmärkte | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.826,0 Mio. EUR, organisches Umsatzwachstum von 2,0 % - Bereinigtes EBITDA liegt bei 195,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,7 % - Unternehmen... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,561 | -0,53 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer | SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet... ► Artikel lesen | |
| SENSEONICS | 6,150 | +1,65 % | Senseonics launches Eversense 365 CGM with Sequel twiist pump | ||
| SYSMEX | 8,750 | 0,00 % | Sysmex H1 Profit Declines | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex Corporation reported that its first half profit attributable to owners of the
parent was 19.0 billion yen, a decline of 26.9% from prior year. Earnings... ► Artikel lesen | |
| AFFINOR GROWERS | 0,009 | 0,00 % | CSE Bulletin: Suspensions - Affinor Growers Inc., Blackbird Critical Metals Corp. | Toronto, Ontario--(Newsfile Corp. - Le 7 octobre/October 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts... ► Artikel lesen | |
| ADDLIFE | 14,270 | -0,76 % | AddLife AB: AddLife acquires Opitek International ApS | AddLife has acquired Opitek International ApS ("Opitek"), a manufacturer specializing in patient positioning. The company will become part of Mediplast, a company within AddLife's Business Area Medtech.AddLife... ► Artikel lesen | |
| EMBECTA | 10,800 | -1,82 % | Dividendenbekanntmachungen (05.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AGRICULTURAL BANK OF CHINA LTD CNE100000Q43 0,1195 CNY 0,0144 EUR AMERISAFE... ► Artikel lesen | |
| ENOVIS | 23,600 | -4,84 % | Enovis Corporation: Enovis Appoints Oliver Engert as Chief Administrative Officer | Dallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,510 | -0,04 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,500 | +1,26 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| FRESENIUS | 49,230 | -1,05 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| BETA BIONICS | 20,550 | -35,76 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen |